SCHEMBL734577

SCHEMBL734577

CN(C)C1(Cc2ccccc2)CC=C(c2[nH]c3ccccc3c2CCCC(=O)O)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.46
OPRM1 P35372 2/20 0.41
OGFRL1 Q5TC84 1/20 0.41
SRC P12931 3/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
PPARG P37231 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
POLB P06746 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPK1 P28482 1/20 0.36
OPRL1 P41146 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14110614 0.92 CDK4 (0.43) EGFRALDH1A1KDM4ESMN1; SMN2
SCHEMBL736123 0.89 POLB (0.45) EGFROPRM1OGFRL1SRCALDH1A1
SCHEMBL734660 0.87 OPRM1 (0.44) OPRM1OGFRL1ALDH1A1KDM4EPPARG
SCHEMBL3932517 0.86 OPRM1 (0.47) OPRM1OGFRL1ALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL734199 0.85 OPRM1 (0.46) OPRM1OGFRL1ALDH1A1KDM4EMAPT
SCHEMBL733852 0.83 OPRM1 (0.41) OPRM1OGFRL1HTR2AHTR2C
SCHEMBL735918 0.82 OPRM1 (0.47) OPRM1OGFRL1ALDH1A1KDM4EMAPT
SCHEMBL734526 0.82 EGFR (0.47) EGFROPRM1OGFRL1SRCALDH1A1
SCHEMBL733644 0.79 OPRM1 (0.41) OPRM1OGFRL1ALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL733593 0.78 OPRM1 (0.41) OPRM1OGFRL1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 EGFR 2940/4885OPRM1 1029/4885OGFRL1 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.